Functional cure, defined as durable hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV) DNA titers below the ...

Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...

Assays for hepatitis B surface antigen (HBsAg) are the most frequently used tests to detect HBV infection. Vaccination for HBV can produce transiently detectable levels of HBsAg in patients.

Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, has announced the expansion of its Hepatitis B research portfolio with a comprehensive range of ...

Abstracts are available on the EASL Congress 2025 website at https://www.easlcongress.eu/. The posters are expected to be ...

The Food and Drug Administration (FDA) has granted Fast Track designation to PBGENE-HBV, an investigational gene editing therapy for adults with chronic hepatitis B.

According to WHO, 254 million people globally were estimated to have HBV in 2022, but only approximately 10% had been ...

However, researchers are working toward improving rates of “functional cure” which is achieved when levels of hepatitis B surface antigen (HBsAg) and HBV DNA become low enough to be ...

the primary source of hepatitis B surface antigen (HBsAg) in late-stage disease. Current treatments for patients with HBV infection include agents that result in long-term viral suppression as ...

Wang Huaqing, chief immunization planning expert at the Chinese Center for Disease Control and Prevention, said the whooping ...

China has made significant progress in vaccine development and immunization, marked by a growing portfolio of domestically ...